Answers are grounded in this paper and cite their sources.
Mitochondrial tRNA-derived small RNAs (mt-tsRNAs), exemplified by mt-tRF-LeuTAA, have emerged as tissue-specific regulators of mitochondrial metabolism and glucose homeostasis. In pancreatic β-cells, mt-tRF-LeuTAA sustains oxidative phosphorylation to support glucose-stimulated insulin secretion; conversely, its downregulation in skeletal muscle enhances insulin sensitivity, indicating bidirectional metabolic control. A more provocative but mechanistically unresolved proposal is that sperm-borne mt-tsRNAs transmit paternal metabolic information across generations. Circulating mt-tsRNAs are also gaining attention as minimally invasive biomarkers, although direct clinical validation remains limited, and their dynamics in early-stage type 2 diabetes and non-alcoholic fatty liver disease are largely unexplored. Their clinical translation is further hindered by the fact that stress-induced cleavage enzymes remain unidentified, detection platforms lack standardized quantification protocols that would ensure cross-study reproducibility, and the electrostatic barrier of the inner mitochondrial membrane poses a substantial obstacle to therapeutic targeting. At present, mt-tsRNAs are best characterized as promising research tools whose value as liquid biopsy biomarkers will depend on rigorous validation in large-scale prospective cohorts with harmonized assay standards.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: